ACOG实践公报2017年7月评论:平均风险女性的乳腺癌风险评估与筛查
该评论总结了美国妇产科医师学会2017年7月实践公报中关于平均风险女性乳腺癌风险评估与筛查的临床管理指南,旨在最大化筛查获益并关注假阳性结果等潜在危害。文章回顾了乳腺X线筛查获益与不良后果的证据,并简要讨论了数字乳腺断层合成和风险适应筛查等新技术进展。
要点
- 乳腺X线筛查可降低平均风险女性乳腺癌死亡率,但存在假阳性、良性活检、焦虑及过度诊断等不良后果。
- USPSTF、ACS、NCCN和ACR/SBI对平均风险女性筛查的起始年龄、停止年龄和频率推荐不一致。
- ACOG 2017年7月实践公报旨在最大化筛查获益并兼顾假阳性结果的潜在危害。
核心结论
- ACOG 2017年7月实践公报针对平均风险女性乳腺癌风险评估与筛查提出临床管理指南,旨在最大化筛查获益并兼顾假阳性结果的潜在危害。
研究设计与样本
- 评论文章,总结美国妇产科医师学会2017年7月实践公报中关于平均风险女性乳腺癌风险评估与筛查的临床管理指南,并回顾乳腺X线筛查获益与不良后果的证据。
临床应用与阅片要点
- USPSTF、ACS、NCCN和ACR/SBI对平均风险女性筛查的起始年龄、停止年龄和频率推荐存在差异。
- ACOG指南旨在最大化筛查获益并兼顾假阳性结果的潜在危害。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Screening mammography reduces breast cancer mortality in average-risk women. However, adverse consequences include false-positive findings possibly leading to benign breast biopsies and patient anxiety. There is also potential for overdiagnosis and overtreatment. Differences in how to balance benefits and harms have led to varying recommendations by the U.S. Preventive Services Task Force, the American Cancer Society, the National Comprehensive Cancer Network and the American College of Radiology/Society of Breast Imaging. These recommendations differ with respect to what age to start, what age to stop, and frequency of screening in average-risk women. Most recently, the American College of Obstetricians and Gynecologists have issued updated clinical management guidelines for breast cancer risk assessment and screening in average-risk women that aim to maximize the benefits of screening while keeping in mind the potential harms of false-positive results. This commentary summarizes the clinical management guidelines of the American College of Obstetricians and Gynecologists Practice Bulletin July 2017 for breast cancer risk assessment and screening in average-risk women. We review evidence of the benefits and adverse consequences of screening mammography and briefly discuss new advances in breast cancer screening with recent technologies such digital breast tomosynthesis and risk-adapted screening.
引用
- Mango V, Bryce Y, Morris EA, et al. Commentary ACOG Practice Bulletin July 2017: Breast Cancer Risk Assessment and Screening in Average-Risk Women. Br J Radiol. 2018. PMID: 29688040. doi:10.1259/bjr.20170907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。